OxyPrem

Zürich, Switzerland

OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants.

$3.2M raised

Aug 2024

Equity Crowdfunding

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OxyPrem raised?

OxyPrem has raised $3.2M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in August 2024.

Who are OxyPrem's investors?

OxyPrem's investors include European Innovation Council, Venture Kick, MassChallenge, Capital Cell.

Where is OxyPrem headquartered?

OxyPrem is headquartered in Zürich, Switzerland.

What does OxyPrem do?

OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants.

What stage is OxyPrem at?

OxyPrem is at the Equity Crowdfunding stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 30, 2024.

MLA

"OxyPrem — Funding & Investors." VCBacked, August 30, 2024, https://www.vcbacked.co/company/oxyprem. Accessed July 1, 2026.

APA

VCBacked. (2024). OxyPrem — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/oxyprem

Wikipedia (cite web)

{{cite web |title=OxyPrem — Funding & Investors |url=https://www.vcbacked.co/company/oxyprem |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 30, 2024.